Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Nina Wressnigg; Eva-Maria Pöllabauer; Gerald Aichinger; Daniel Portsmouth; Alexandra Löw-Baselli; Sandor Fritsch; Ian Livey; Brian A Crowe; Michael Schwendinger; Peter Brühl; Andreas Pilz; Thomas Dvorak; Julia Singer; Clair Firth; Benjamin Luft; Bernhard Schmitt; Markus Zeitlinger; Markus Müller; Herwig Kollaritsch; Maria Paulke-Korinek; Meral Esen; Peter G Kremsner; Hartmut J Ehrlich; P Noel Barrett

The Lancet Infectious Diseases (2013) - Comments
doi: 10.1016/s1473-3099(13)70110-5 issn: 1473-3099 pubmed: 23665341

Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger, Daniel Portsmouth, Alexandra Löw-Baselli, Sandor Fritsch, Ian Livey, Brian A Crowe, Michael Schwendinger, Peter Brühl, Andreas Pilz, Thomas Dvorak, Julia Singer, Clair Firth, Benjamin Luft, Bernhard Schmitt, Markus Zeitlinger, Markus Müller, Herwig Kollaritsch, Maria Paulke-Korinek